ArticleStem cells translational medicine2026
A Phase 1 clinical trial to evaluate the safety and tolerability of CLZ-2002 for the treatment of patients with Charcot-Marie-Tooth disease type 1.
Hyesun Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.